retatrutide dosing phase 2 trial Let's talk about a new weight loss medication: retrarutide. is a triple hormone receptor agonist that suppresses appetite; it also boosts metabolism and increases fat burning, making it one of the Retatrutide vs Tirzepatide: Which Peptide

doi: 10.1016/j.neurobiolaging.2012.04.009 53 KellyPMcCleanPLAckermannMKonerdingMAHlscherCMitchellCA

Any images of individuals on this site are for illustrative purposes only and feature models

2022 Aug;24(8):1553-1564

Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment

Accelerated regulatory pathways for innovative medicines and the growing presence of regional biotechnology companies are strengthening the country's position as a major GLP-1 research and production hub

The high price of GLP-1 drugs could be substantially reduced in the future once they come off patent thereby allowing for the introduction of biosimilars